Document Detail


Effect of replacement doses of thyroxine on bone mineral density.
MedLine Citation:
PMID:  9579237     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Hyperthyroidism is associated with a reduction in bone mineral density (BMD). Suppressive doses of thyroxine (T4), inducing subclinical hyperthyroidism, have been reported by some investigators to reduce BMD. Little work has been done on replacement doses of T4. AIM: The aim was to investigate the effect of replacement doses of T4 on BMD. STUDY DESIGN: Cross-sectional study of hypothyroid patients on long-term T4 replacement doses, comparing those who had primary hypothyroidism with those who were previously hyperthyroid. PATIENTS: Fifty women on replacement doses of T4 for more than 5 years were recruited. Twenty-five were treated for primary (group 1) and 25 for radioiodine-induced hypothyroidism (group 2). They were well matched for age, menstrual status, smoking history, body mass index (BMI), dose and duration of T4 replacement as well as thyroid status. MEASUREMENTS: BMD was assessed by dual energy X-ray absorptiometry. Free T4 (FT4), FT3 as well as ultrasensitive TSH assays were used to assess thyroid status. RESULTS: The two groups showed no difference in BMD (g/cm2) of the lumbar spine (1.008 vs. 0.957, P = 0.25), femoral neck (0.745 vs. 0.735, P = 0.79) and total hip (0.878 vs. 0.837, P = 0.24). When the two groups were pooled, there was no significant difference between the patients and a reference population with femoral neck and total hip BMD expressed as a standard deviation (Z) score. However, the lumbar spine mean Z score was significantly greater than zero. For each site, there was a negative correlation of BMD with age in at least one group but, in general, BMI, FT4, FT3 and duration of T4 replacement did not correlate with BMD. T4 dose, however, had a consistent positive correlation with BMD in the spine, femoral neck and the hip (P = 0.01, 0.04 and 0.02, respectively) in group 2 but not group 1. CONCLUSION: In this study, there is no evidence for a difference in bone mineral density in patients receiving replacement doses of thyroxine irrespective of the aetiology of their hypothyroidism. The reduced bone mineral density associated with hyperthyroidism appears to be restored, maintained and in some cases possibly improved while on long-term thyroxine replacement post-radioiodine.
Authors:
F W Hanna; R J Pettit; F Ammari; W D Evans; D Sandeman; J H Lazarus
Related Documents :
24353877 - Effect of magnesium and calcium phosphate coatings on osteoblastic responses to the tit...
3492367 - Monoclonal antibodies can enhance the biological activity of thyrotropin.
6725867 - Thiocyanates and iodine in endemic goiter in italy.
7762527 - New model for describing urinary iodine excretion: its use for comparing different oral...
19687017 - Cumulative patient effective dose and acute radiation-induced chromosomal dna damage in...
3840817 - Role of seminal prostaglandins in male fertility. ii. effects of prostaglandin synthesi...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Clinical endocrinology     Volume:  48     ISSN:  0300-0664     ISO Abbreviation:  Clin. Endocrinol. (Oxf)     Publication Date:  1998 Feb 
Date Detail:
Created Date:  1998-05-26     Completed Date:  1998-05-26     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0346653     Medline TA:  Clin Endocrinol (Oxf)     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  229-34     Citation Subset:  IM    
Affiliation:
Department of Medicine, University of Wales College of Medicine, Cardiff, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Absorptiometry, Photon
Bone Density / drug effects*
Female
Humans
Hyperthyroidism / radiotherapy
Hypothyroidism / drug therapy*,  etiology,  physiopathology*
Middle Aged
Regression Analysis
Thyroid Function Tests
Thyroxine / therapeutic use*
Chemical
Reg. No./Substance:
7488-70-2/Thyroxine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dexamethasone in the diagnostic work-up of growth hormone deficiency.
Next Document:  Effect of food intake on the pharmacokinetics and antidiuretic activity of oral desmopressin (DDAVP)...